Figure 5From: Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis Forest plot for the association between BRCA1 level and objective response rate (ORR) in toxal-based treatment. Back to article page